Mohammad Mehdi Sadoughi1,2, Bahram Einollahi3, Alireza Baradaran-Rafii3, Danial Roshandel3, Hamidreza Hasani3, Mehrdad Nazeri4. 1. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. sadoughi_mm@yahoo.com. 2. Department of Ophthalmology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. sadoughi_mm@yahoo.com. 3. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 4. Scientific Educational Ophthalmology Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract
PURPOSE: To compare the outcomes of the conventional and accelerated corneal collagen cross-linking (CXL) in patients with bilateral progressive keratoconus (KC). METHODS:Fifteen consecutive patients with bilateral progressive KC were enrolled. In each patient, the fellow eyes were randomly assigned to the conventional CXL (3 mW/cm2 for 30 min) or accelerated CXL (ACXL) (9 mW/cm2 for 10 min) groups. Manifest refraction; uncorrected and corrected distant visual acuity; maximum and mean keratometry; corneal hysteresis and corneal resistance factor; endothelial cell density and morphology; central corneal thickness; and wavefront aberrations were measured before and 12 months after the CXL. RESULTS:Manifest refraction spherical equivalent and refractive cylinder improved significantly only in conventional group. Uncorrected and corrected distant visual acuity did not change significantly in either group. Also there was no significant change in the maximum and mean keratometry after 12 months. There was significant decrease in central corneal thickness in both groups which was more prominent in conventional group. Endothelial cell density reduced only in the conventional group which was not statistically significant (P = 0.147). CH, CRF, and wavefront aberrations did not change significantly in either group. We did not observe any significant difference in the changes of the variables between the two groups. CONCLUSIONS: Accelerated CXL with 9 mW/cm2 irradiation for 10 min had similar refractive, visual, keratometric, and aberrometric results and less adverse effects on the corneal thickness and endothelial cells as compared with the conventional method after 12 months follow-up. However, randomized clinical trials with longer follow-ups and larger sample sizes are needed.
RCT Entities:
PURPOSE: To compare the outcomes of the conventional and accelerated corneal collagen cross-linking (CXL) in patients with bilateral progressive keratoconus (KC). METHODS: Fifteen consecutive patients with bilateral progressive KC were enrolled. In each patient, the fellow eyes were randomly assigned to the conventional CXL (3 mW/cm2 for 30 min) or accelerated CXL (ACXL) (9 mW/cm2 for 10 min) groups. Manifest refraction; uncorrected and corrected distant visual acuity; maximum and mean keratometry; corneal hysteresis and corneal resistance factor; endothelial cell density and morphology; central corneal thickness; and wavefront aberrations were measured before and 12 months after the CXL. RESULTS: Manifest refraction spherical equivalent and refractive cylinder improved significantly only in conventional group. Uncorrected and corrected distant visual acuity did not change significantly in either group. Also there was no significant change in the maximum and mean keratometry after 12 months. There was significant decrease in central corneal thickness in both groups which was more prominent in conventional group. Endothelial cell density reduced only in the conventional group which was not statistically significant (P = 0.147). CH, CRF, and wavefront aberrations did not change significantly in either group. We did not observe any significant difference in the changes of the variables between the two groups. CONCLUSIONS: Accelerated CXL with 9 mW/cm2 irradiation for 10 min had similar refractive, visual, keratometric, and aberrometric results and less adverse effects on the corneal thickness and endothelial cells as compared with the conventional method after 12 months follow-up. However, randomized clinical trials with longer follow-ups and larger sample sizes are needed.
Authors: María A Del Buey; Elena Lanchares; José Ángel Cristóbal; Santiago Ramón Y Cajal Junquera; Carmen Yus Gotor; Begoña Calvo Journal: J Refract Surg Date: 2015-01 Impact factor: 3.573
Authors: George D Kymionis; Michael A Grentzelos; Dimitrios A Liakopoulos; Theodoros A Paraskevopoulos; Nektarios E Klados; Konstantinos I Tsoulnaras; Vardhaman P Kankariya; Ioannis G Pallikaris Journal: Cornea Date: 2014-10 Impact factor: 2.651
Authors: George D Kymionis; Michael A Grentzelos; Dimitra M Portaliou; Vardhaman P Kankariya; J Bradley Randleman Journal: J Refract Surg Date: 2014-08 Impact factor: 3.573
Authors: George D Kymionis; George A Kounis; Dimitra M Portaliou; Michael A Grentzelos; Alexandra E Karavitaki; Efekan Coskunseven; Mirko R Jankov; Ioannis G Pallikaris Journal: Ophthalmology Date: 2009-10-22 Impact factor: 12.079
Authors: Konstantinos D Andreanos; Kate Hashemi; Myrsini Petrelli; Konstantinos Droutsas; Ilias Georgalas; George D Kymionis Journal: Ophthalmol Ther Date: 2017-07-28